Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer

Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer

NCT01654367 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer

NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3

Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy

NCT01613560 ·Status: UNKNOWN ·Phase: PHASE2

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

NCT02097459 ·Status: UNKNOWN ·Phase: PHASE3

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

NCT01176916 ·Status: COMPLETED ·Phase: PHASE4

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

NCT00544986 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer

NCT00006030 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

NCT02132000 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

NCT01237327 ·Status: COMPLETED ·Phase: PHASE3

Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer

NCT00002581 ·Status: COMPLETED ·Phase: PHASE3

Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women

NCT01300351 ·Status: COMPLETED ·Phase: PHASE3

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

NCT05801705 ·Status: UNKNOWN

Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer

NCT01612871 ·Status: COMPLETED ·Phase: PHASE4

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

NCT00516698 ·Status: COMPLETED

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

NCT00005886 ·Status: COMPLETED ·Phase: PHASE1

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

NCT01431053 ·Status: UNKNOWN ·Phase: PHASE2

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 ·Status: COMPLETED ·Phase: PHASE2

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

NCT00309491 ·Status: COMPLETED ·Phase: PHASE3

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

NCT02598557 ·Status: COMPLETED ·Phase: PHASE2

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

NCT00562458 ·Status: COMPLETED

Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

NCT02089854 ·Status: UNKNOWN ·Phase: PHASE4

Tamoxifen in Treating Women With Breast Cancer

NCT00003678 ·Status: UNKNOWN ·Phase: PHASE3

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer

NCT00032136 ·Status: COMPLETED ·Phase: PHASE3

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

NCT06033092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2